Wolverine Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wolverine Trading’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,920	Closed	-$1.44M	–	5879
2021 Q3	$1.44M	Buy	+1,920	New	+$1.44M	﹤0.01%	2531
2021 Q2	–	Sell	-523	Closed	-$295K	–	5996
2021 Q1	$295K	Buy	+523	New	+$310K	﹤0.01%	4491
2020 Q3	–	Sell	-683	Closed	-$346K	–	4495
2020 Q2	$295K	Sell	683 -252	-27%	-$111K	﹤0.01%	3366
2020 Q1	$326K	Buy	+935	New	+$344K	﹤0.01%	3125
2017 Q1	–	Sell	-1,906	Closed	-$347K	–	4258
2016 Q4	$347K	Buy	1,906 +59	+3%	+$10.1K	﹤0.01%	3081
2016 Q3	$299K	Buy	+1,847	New	+$280K	﹤0.01%	3240

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Wolverine Trading's BIO Position: Q4 2021 in Review

Wolverine Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 1,920 shares — an estimated $1.44M sold.

Wolverine Trading first reported a position in BIO in Q3 2016 and held it in 6 quarters. The position peaked at $1.44M in Q3 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

Wolverine Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 1,920 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $1.44M.
Wolverine Trading first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 6 quarters.
Wolverine Trading's Bio-Rad Laboratories Class A position peaked at $1.44M in Q3 2021.
533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.